Patents by Inventor Davy Jérémy BAUDELET

Davy Jérémy BAUDELET has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • P2RX7 modulators in therapy
    Patent number: 11919854
    Abstract: The present invention relates to compounds of formula (I), their enantiomers and their pharmaceutically acceptable salts, and their use in therapy, particularly for the treatment of cancer or inflammatory diseases.
    Type: Grant
    Filed: March 29, 2019
    Date of Patent: March 5, 2024
    Assignees: CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, CHRU DE LILLE, UNIVERSITE COTE D'AZUR, INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM), UNIVERSITE DE LILLE, JUNIA
    Inventors: Valérie Vouret, Laetitia Douguet, Alina Ghinet, Germain Homerin, Benoît Guy Marie Rigo, Davy Jérémy Baudelet, Xavier Dezitter, Régis Millet, Christophe Furman
  • SOMATOSTATIN RECEPTOR ANTAGONIST COMPOUNDS AND METHODS OF USING THE SAME
    Publication number: 20220112242
    Abstract: The present invention is directed to somatostatin receptor antagonist compounds having the structure of Formula I: compositions comprising the same, and methods of using such compounds and compositions. The compounds may be useful in the prevention or treatment of hypoglycemia.
    Type: Application
    Filed: December 29, 2021
    Publication date: April 14, 2022
    Inventors: STEPHEN PAUL ARNS, JAMES BRIAN JAQUITH, DAVY JEREMY BAUDELET, ERIC ROY SIMONSON, RICHARD TOM LIGGINS, NAG SHARWAN KUMAR, TOM HAN HSIAO HSIEH
  • Somatostatin receptor antagonist compounds and methods of using the same
    Patent number: 11279732
    Abstract: The present invention is directed to somatostatin receptor antagonist compounds having the structure of Formula I, compositions comprising the same, and methods of using such compounds and compositions. The compounds may be useful in the prevention or treatment of hypoglycemia.
    Type: Grant
    Filed: February 9, 2017
    Date of Patent: March 22, 2022
    Assignee: CDRD VENTURES INC.
    Inventors: Stephen Paul Arns, James Brian Jaquith, Davy Jérémy Baudelet, Eric Roy Simonson, Richard Tom Liggins, Nag Sharwan Kumar, Tom Han Hsiao Hsieh
  • P2RX7 MODULATORS IN THERAPY
    Publication number: 20210017131
    Abstract: The present invention relates to compounds of formula (I), their enantiomers and their pharmaceutically acceptable salts, and their use in therapy, particularly for the prevention and/or treatment of cancer or inflammatory diseases.
    Type: Application
    Filed: March 29, 2019
    Publication date: January 21, 2021
    Inventors: Valérie Vouret, Laetitia Douguet, Alina Ghinet, Germain Homerin, Benoît Guy Marie Rigo, Davy Jérémy Baudelet, Xavier Dezitter, Régis Millet, Christophe Furman
  • SOMATOSTATIN RECEPTOR ANTAGONIST COMPOUNDS AND METHODS OF USING THE SAME
    Publication number: 20190040102
    Abstract: The present invention is directed to somatostatin receptor antagonist compounds having the structure of Formula I, compositions comprising the same, and methods of using such compounds and compositions. The compounds may be useful in the prevention or treatment of hypoglycemia.
    Type: Application
    Filed: February 9, 2017
    Publication date: February 7, 2019
    Inventors: Stephen Paul ARNS, James Brian JAQUITH, Davy Jérémy BAUDELET, Eric Roy SIMONSON, Richard Tom LIGGINS, Nag Sharwan KUMAR, Tom Han Hsiao HSIEH